- Abscess
- Aspergillosis
- Bacterial infections
- Blastomycosis
- Cellulitis
- Clostridium difficile infection
- COVID-19 virus disease
- Encephalitis
- Epstein-Barr virus (EBV)
- Fever of unknown origin
- Flu (influenza)
- Fungal infection
- Helicobacter pylori (H. Pylori)
- Histoplasmosis
- Infectious complications with solid tumor
- Infectious disease
- Latent tuberculosis (LTBI)
- Lyme disease
- Lymphadenopathy (Enlarged lymph nodes)
- Meningitis
- Methicillin resistant staphylococcus aureus (MRSA)
- Parasitic infections
- Pneumonia
- Positive QuantiFERON gold test result
- Pulmonary tuberculosis (TB)
- Shingles
- Skin infections
- Skin rash
- Staphylococcal infections
- Travel-associated infection
- Traveler's diarrhea
- Tropical medicine
- Urinary tract infection
- Viral infectious disorders
- Wound infection
Michael Z. David, MD, PhD
About me
- Director, Methicillin-Resistant Staphylococcus aureus Program
- Associate Professor of Medicine (Infectious Diseases) at the Hospital of the University of Pennsylvania
- Associate Professor of Epidemiology in Biostatistics and Epidemiology
My education and training
- Medical School: Yale University School of Medicine
- Residency: Yale-New Haven Hospital
- Fellowship: University of Chicago Medical Center
Spoken languages
Reviews
80 reviews
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Insurance accepted
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Qualifications and experience
- Infectious Disease, 2009
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID), International
- Infectious Diseases Society of America (IDSA), National
- International Society of Antimicrobial Chemotherapy (ISAC), International
- National Institutes of Health, National
- Society for Healthcare Epidemiology of America (SHEA), National
- The Association for Slavic, East European, and Eurasian Studies (ASEEES), National
- University of Pennsylvania, University Research Foundation Biomed Panel,, Local
Treatments and conditions
Research
Publications
David MZ MRSA community pneumonia: A global perspective on resistance , Lancet Infect Dis, 16(12): 2016,1309-10
Alam T, Reed T, Sieth J, Kumar N, Miller LG, Eells S, Boyle-Vavra S, Daum RS, David MZ Transmission and microevolution of USA300 MRSA in U.S. households: Evidence from whole-genome sequencing , mBio, 6(2): 2015,e00054-15
David MZ, Dryden M, Gottlieb T, Tattevin P, Gould IM Recently approved new antibacterials for Gram positive bacteria: The shock of the new , Int J Antimicrob Agents, 50(3): 2017,303-307
Azarian T, Petty L, Steinbeck J, Michel A, Yin Z, Boyle-Vavra S, Daum RS, David MZ Intrahost evolution of methicillin-resistant Staphylococcus aureus USA300 among individuals with reoccurring skin and soft-tissue infections , J Infect Dis, 214(6): 2016,895-905
Carrel M, Perencevich E, David MZ USA300 methicillin-resistant Staphylococcus aureus, United States, 2000-2013 , Emerg Infect Dis, 21(11): 2015,1973-80
Alegre ML, Chen L, David MZ, Bartman C, Boyle-Vavra S, Kumar N, Chong AS, Daum RS Impact of Staphylococcus aureus USA300 colonization and skin infections on systemic immune responses in humans , J Immunol, 197(4): 2016,1118-1126
David MZ, Siegel JD, Henderson J, Leos G, Lo K, Porsa E, Schumm P, Boyle-Vavra S, Daum RS A randomized, controlled trial of chlorhexidine-soaked cloths to reduce methicillin-resistant and methicillin-susceptible Staphylococcus aureus carriage prevalence in an urban jail , Infect Control Hosp Epidemiol, 35(12): 2014,1466-73
Miller LG, Eells SJ, Taylor AR, David MZ, Ortiz N, Zychowski D, Kumar N, Cruz D, Boyle-Vavra S, Daum RS Staphylococcus aureus skin infection recurrences among household members: An examination of host, behavioral, and pathogen level predictors , Clin Infect Dis, 60(5): 2015,753-63
Shah N, McNulty M, Greenberg JA, Riddell J, Gregg KS, Mangino JE, Weber D, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino C, Green Hines A, Bares S, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani FJ, Abbas Z, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013-14 , J Clin Virol, 80(1): 2016,12-19